Short Contents | Full Contents | Other books NCBI |
|
AHRQ Evidence reports and summaries AHRQ Evidence Reports, Numbers 61 - 119 81. Diagnosis and Treatment of Coronary Heart Disease in Women: Systematic Reviews of Evidence on Selected Topics Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services www.ahrq.gov Contract No. 290-97-0013 Prepared by: University of California, San Francisco-Stanford University Evidence-based Practice Center, Stanford, CA Principal Investigator Deborah Grady, MD, MPH EPC Coordinator Kathryn McDonald, MM EPC Staff Kara Bischoff Aurelie Cabou Christopher Gehrman Kate Hoerster Lily Chaput, MD, MPH Margaret Kristof, MS, RN Kathryn Melsop, MS Dan H. Moore, PhD Topic Team Staff Noninvasive Diagnostic Tests Mary Beattie, MD Louise Metz, MD Kirsten Fleishmann, MD Rita Redberg, MD Lipid Lowering Treatment Judith Walsh, MD, MPH Michael Pignone, MD, MPH Paul Varosy, MD Diabetes as Risk Factor Alka Kanaya, MD Lily Chaput, MD, MPH Troponins Paul Heindenreich, MD Kathy McDonald, MM UCSF/Mt. Zion Fishbon Library Staff Gail Sorrough, MLIS Gloria Won, MLIS AHRQ Publication No. 03-E037 May 2003 ISBN: 1-58763-086-9 ISSN: 1530-4396 This document is in the public domain and may be used and reprinted without permission except those copyrighted materials noted for which further reproduction is prohibited without the specific permission of copyright holders. Suggested Citation: Grady D, Chaput L, Kristof M. Diagnosis and Treatment of Coronary Heart Disease in Women: Systematic Reviews of Evidence on Selected Topics. Evidence Report/Technology Assessment No. 81. (Prepared by the University of California, San Francisco-Stanford Evidence-based Practice Center under Contract No 290-97-0013.) AHRQ Publication No. 03-E037. Rockville, MD: Agency for Healthcare Research and Quality. May 2003. This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied. AHRQ is the lead Federal agency charged with supporting research designed to improve the quality of health care, reduce its cost, address patient safety and medical errors, and broaden access to essential services. AHRQ sponsors and conducts research that provides evidence-based information on health care outcomes; quality; and cost, use, and access. The information helps health care decisionmakerspatients and clinicians, health system leaders, and policymakersmake more informed decisions and improve the quality of health care services. |